1.Bone marrow metastasis presenting as bicytopenia originating from hepatocellular carcinoma.
Young Mi HONG ; Ki Tae YOON ; Mong CHO ; Dae Hwan KANG ; Hyung Wook KIM ; Cheol Woong CHOI ; Su Bum PARK ; Jeong HEO ; Hyun Young WOO ; Won LIM ; S M BAKHTIAR UI ISLAM
Clinical and Molecular Hepatology 2016;22(2):267-271
The bone is a common site for metastasis in hepatocellular carcinoma (HCC). However, bone marrow metastasis from HCC is rarely reported, and its frequency is unclear. Here we report a rare case of bone marrow metastasis that presented as bicytopenia originating from HCC without bone metastasis. A 58-year-old man was admitted for investigation of a liver mass with extensive lymph node enlargement that was detected when examining his general weakness and weight loss. Laboratory findings revealed anemia, thrombocytopenia, mild elevated liver enzymes, normal prothrombin time percentage and high levels of tumor markers (α-fetoprotein and des-γ-carboxyprothrombin). Abdominal computed tomography showed multiple enhanced masses in the liver and multiple enlarged lymph nodes in the abdomen. A bone marrow biopsy revealed only a few normal hematopoietic cells and abundant tumor cells. Despite its rarity, bone marrow metastasis should always be suspected in HCC patients even if accompanied by cirrhosis.
Biomarkers/analysis
;
Bone Marrow/*pathology
;
Carcinoma, Hepatocellular/*diagnosis
;
Humans
;
Liver Neoplasms/*diagnosis
;
Male
;
Middle Aged
;
Neoplasm Metastasis
;
Positron Emission Tomography Computed Tomography
;
Protein Precursors/analysis
;
Prothrombin/analysis
;
Thrombocytopenia/diagnosis
;
Tomography, X-Ray Computed
;
alpha-Fetoproteins/analysis
2.Antidiabetic and Beta Cell-Protection Activities of Purple Corn Anthocyanins.
Su Hee HONG ; Jee In HEO ; Jeong Hyeon KIM ; Sang Oh KWON ; Kyung Mok YEO ; Anna M BAKOWSKA-BARCZAK ; Paul KOLODZIEJCZYK ; Ok Hyun RYU ; Moon Ki CHOI ; Young Hee KANG ; Soon Sung LIM ; Hong Won SUH ; Sung Oh HUH ; Jae Yong LEE
Biomolecules & Therapeutics 2013;21(4):284-289
Antidiabetic and beta cell-protection activities of purple corn anthocyanins (PCA) were examined in pancreatic beta cell culture and db/db mice. Only PCA among several plant anthocyanins and polyphenols showed insulin secretion activity in culture of HIT-T15 cells. PCA had excellent antihyperglycemic activity (in terms of blood glucose level and OGTT) and HbA1c-decreasing activity when compared with glimepiride, a sulfonylurea in db/db mice. In addition, PCA showed efficient protection activity of pancreatic beta cell from cell death in HIT-T15 cell culture and db/db mice. The result showed that PCA had antidiabetic and beta cell-protection activities in pancreatic beta cell culture and db/db mice.
Animals
;
Anthocyanins*
;
Blood Glucose
;
Cell Culture Techniques
;
Cell Death
;
Insulin
;
Insulin-Secreting Cells
;
Mice
;
Passive Cutaneous Anaphylaxis
;
Plants
;
Polyphenols
;
Zea mays*
3.Clinical Report of 46 Intracranial Tumors with LINAC Based Stereotactic Radiosurgery.
Sei C YOON ; Tae S SUH ; Sung W KIM ; Ki M KANG ; Yun S KIM ; Byung O CHOI ; Hong S JANG ; Kyo H CHOI ; Moon C KIM ; Kyung S SHINN
Journal of the Korean Society for Therapeutic Radiology 1993;11(2):241-248
Between July 1988 and December 1992, we treated 45 patients who had deep seated inoperable or residual and/or recurrent intracranial tumors using LINAC based stereotactic radiosurgery at the Department of Therapeutic Radiology, Kangnam St. Mary's Hospital, Catholic University Medical College. Treated intracranial tumors included pituitary tumors(n=15), acoustic neurinomas(n=8), meningiomas(n=7), gliomas(n=6), craniopharyngiomas(n=4), pinealomas(n=3), hemangioblastomas(n=2), and solitary metastatic tumor from lung cancer (n=1). The dimension of treatment field varied from 0.23 to 42.88 cm3(mean ; 7.26 cm3). The maximum tumor doses ranging from 5 to 35.5 Gy (mean; 29.9 Gy) were given, and depended on patients' age, target volume, location of lesion and previous history of irradiation. There were 22 male and 23 female patients. The age was varied from 5 to 74 years of age(a median age; 43 years). The mean duration of follow-up was 35 months (2~55 months). To date, 18(35.1%) of 46 intracranial tumors treated with SRS showed absent or decrease of the tumor by serial follow-up CT and/or MRI and 16(34.8%) were stationary, e.g. growth arrest. From the view point of the clinical aspects, 34(73.9%) of 46 tumors were considered improved status, that is, alive with no evidence of active tumor and 8(17.4%) of them were stable, alive with disease but no deterioration as compared with before SRS. Although there showed slight increase of the tumor in size according to follow-up imagings of 4 cases(pituitary tumor 1, acoustic neurinomas 2, pinealoma 1), they still represented clinically stable status. Clinically, two(4.4%) patients who were anaplastic astrocytoma(n=1) and metastatic brain tumor(n=1) were worsened following SRS treatment. So far, no serious complications were found after treatment. The minor degree headache which could be relieved by steroid or analgesics and transient focal hair loss were observed in a few cases. There should be meticulous long term follow-up in all cases.
Acoustics
;
Analgesics
;
Brain
;
Craniopharyngioma
;
Female
;
Follow-Up Studies
;
Glioma
;
Hair
;
Headache
;
Hemangioblastoma
;
Humans
;
Lung Neoplasms
;
Magnetic Resonance Imaging
;
Male
;
Meningioma
;
Neuroma, Acoustic
;
Pinealoma
;
Pituitary Neoplasms
;
Radiation Oncology
;
Radiosurgery*